Saudi Arabia Ophthalmic Devices Market Analysis by Mordor Intelligence
The Saudi Arabia ophthalmic devices market size is valued at USD 0.58 billion in 2025 and is forecast to reach USD 0.77 billion by 2030, registering a 5.76% CAGR. This advance is anchored in Vision 2030’s USD 65 billion healthcare-modernization plan. Sustained demand arises from a diabetes burden that climbed to 7 million cases in 2021 and is expected to hit 8.4 million by 2030, heightening the need for screening and monitoring technologies. Rapid adoption of artificial-intelligence (AI) diagnostics, growing private investment in ambulatory eye-care centers, and the emergence of Riyadh and Jeddah as medical-tourism hubs further energize the Saudi Arabia ophthalmic devices market. Headwinds persist, however, in the form of import dependency that raises device prices and a shortage of certified technicians, which limits throughput despite equipment availability. Policymakers are therefore refining Saudi Food and Drug Authority (SFDA) procedures and funding training pipelines to ease these constraints.
Key Report Takeaways
- By device type, vision care devices held 60.41% of the Saudi Arabia ophthalmic devices market share in 2024; Diagnostic & monitoring devices are projected to expand at a 7.86% CAGR through 2030.
- By disease indication, cataract accounted for 35.61% of the Saudi Arabia ophthalmic devices market size in 2024, while Diabetic retinopathy is set to grow at a 7.04% CAGR to 2030.
- By end-user, hospitals commanded 45.71% revenue share in 2024; Ambulatory surgery centers are expected to post a 6.92% CAGR during 2025-2030.
Saudi Arabia Ophthalmic Devices Market Trends and Insights
Driver Impact Analysis
| Driver | % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Government-funded Vision 2030 ophthalmology infrastructure expansion | +1.8% | Riyadh, Jeddah, Eastern Province | Medium term (2-4 years) |
| High diabetes prevalence driving AI-based diabetic-retinopathy screening uptake | +1.2% | Nationwide; strongest in Western region | Long term (≥ 4 years) |
| Compulsory pre-marital & school eye-health screening programmes | +0.8% | Initially urban, then national | Medium term (2-4 years) |
| Rise of premium elective LASIK & cataract surgeries via medical-tourism hubs (Riyadh, Jeddah) | +0.9% | Riyadh and Jeddah | Short term (≤ 2 years) |
| Emergence of public–private ophthalmic centres of excellence under NHC PPP model | +0.6% | Major metropolitan areas | Medium term (2-4 years) |
| Rapid adoption of cloud-connected OCT & fundus cameras in primary-care polyclinics | +0.5% | Nationwide | Short term (≤ 2 years) |
| Source: Mordor Intelligence | |||
Government-Funded Vision 2030 Ophthalmology Infrastructure Expansion
Vision 2030 seeks to raise private-sector participation in healthcare to 68% by 2030 and add about 84,000 beds to reach OECD standards[1]Vision 2030 Program, “SEHA Virtual Hospital Overview,” vision2030.gov.sa. Expansion plans by large hospital groups—such as Dr Sulaiman Al Habib Medical Services, which intends to grow capacity from 1,913 to 3,609 beds by 2028—translate directly into higher purchases of surgical microscopes, optical-coherence-tomography (OCT) scanners, and tele-ophthalmology platforms. The SEHA Virtual Hospital now links more than 150 hospitals, enabling remote retinal assessments and extending specialist reach.
High Diabetes Prevalence Driving AI-Based Diabetic-Retinopathy Screening Uptake
Diabetes affects 31.0% of adults in the Kingdom, and diabetic retinopathy (DR) impacts 46% of diabetics in the Western region. An AI-enabled national tele-retinopathy programme launched in 2024 accelerates screening throughput and accuracy. Early results indicate a 30.0% reduction in unnecessary referrals, spurring demand for AI-ready fundus cameras and cloud-integrated image-management systems. Persistent knowledge gaps—29% of patients report never having had an eye exam—are addressed by payer-funded awareness drives that should boost device utilisation.
Compulsory Premarital & School Eye-Health Screening Programmes
Mandatory premarital genetic screening, in place since 2004, still lacks comprehensive ocular testing despite high hereditary-eye-disease prevalence. Consanguinity accounts for 87.2% of paediatric strabismus cases, highlighting scope for portable autorefractors in primary-care clinics. School screening remains ad-hoc; a Qassim study found a 26.6% vision-test failure rate among preschoolers, signalling strong latent demand for handheld diagnostic kits[2]Naif Almutairi, “Primary Health-Care Eye Services in Saudi Arabia,” sciencedirect.com. Parents show high awareness yet limited follow-through on regular eye checks, suggesting growth potential once national guidelines are enacted.
Rise of Premium Elective LASIK & Cataract Surgeries Via Medical-Tourism Hubs
Riyadh and Jeddah position themselves as regional centers for high-end eye surgery. Magrabi Health alone performs more than 200,000 procedures annually across 40 sites, having pioneered LASIK in the region. Competitive bundled pricing draws Gulf patients, supporting steady demand for femtosecond-laser systems, premium intra-ocular lenses, and advanced diagnostics. Alcon strengthened this premium ecosystem by opening the Middle East’s first Alcon Experience Center in Jeddah in March 2025.
Restraints Impact Analysis
| Restraints Impact Analysis | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Import-dependence inflating device prices post-tariff harmonisation (SFDA) | −1.2% | Nationwide; premium segments | Short term (≤ 2 years) |
| Shortage of certified ophthalmic technicians limiting diagnostic throughput | −0.9% | Rural regions most affected | Medium term (2-4 years) |
| Lengthy SFDA device-registration timelines delaying launches | −0.7% | Nationwide | Short term (≤ 2 years) |
| Price-sensitive contact-lens e-commerce dampening uptake of premium vision-care devices | −0.4% | Nationwide; strongest in urban e-commerce channels | Short term (≤ 2 years) |
| Source: Mordor Intelligence | |||
Import Dependence Inflating Device Prices
The SFDA mandates ISO 13485 certification and local Authorised Representatives, raising import-transaction costs. Beginning January 2025, all medical devices also require SABER platform conformity certificates, which add compliance fees that sellers pass through to buyers. These expenses elevate landed costs—particularly for premium imaging equipment—by an estimated 15%, dampening uptake in smaller clinics.
Shortage of Certified Ophthalmic Technicians Limiting Diagnostic Throughput
Saudi Arabia hosts 2,608 ophthalmologists (81.06 per million people), surpassing WHO guidelines, yet only 38% are nationals and distribution is uneven: Riyadh has 75.6 per million versus 42.8 per million in Jazan[3]Khalid Aldebasi, “Ophthalmologist Distribution in Saudi Regions,” ncbi.nlm.nih.gov. At the technician level, only 0.47% of primary-care centers provide optometry services, so high-value devices such as OCT scanners often sit under-utilised. Government scholarships and fast-track licensing aim to close the skills gap but will take years to yield a balanced workforce.
Segment Analysis
By Device Type: Diagnostic Equipment Accelerates Innovation
Vision care devices retained a 60.41% share of the Saudi Arabia ophthalmic devices market in 2024, supported by steady demand for spectacles, contact lenses, and dispensing systems. Diagnostic & Monitoring Devices, however, are set to expand at a 7.86% CAGR through 2030, reflecting hospitals’ shift toward early-stage disease identification. Within this cluster, optical-coherence-tomography scanners should command 24.42% of diagnostic revenue in 2024, benefiting from superior retinal-layer visualisation that aids macular-degeneration and diabetic-retinopathy screening. Ultra-wide-field fundus cameras also post strong orders because clinicians want comprehensive peripheral-retina images to detect lesions missed by 45-degree systems.
The diagnostic up-cycle is reinforced by national tele-health mandates that integrate cloud-based image management and AI grading. As a result, the Saudi Arabia ophthalmic devices market size allocated to diagnostic hardware rises in tandem with digitally linked screening programmes. Surgical-device demand grows at a moderate clip, buoyed by premium intra-ocular-lens adoption in elective cataract and refractive procedures popular in Riyadh and Jeddah. Import tariffs remain a drag on smaller buyers, but multinational suppliers offset duties with leasing options and bundled-service contracts.
Note: Segment shares of all individual segments available upon report purchase
By Disease Indication: Diabetic Retinopathy Drives Digital Transformation
Cataract retained 35.61% of revenue in 2024, reflecting an ageing population and high surgery volumes in public hospitals. Diabetic retinopathy now registers the fastest growth trajectory with a 7.04% CAGR forecast for 2025-2030, propelled by a diabetes prevalence that reached 7 million patients in 2021. The Saudi Arabia ophthalmic devices market size tied to diabetic-retinopathy care is therefore climbing quickly as payers subsidise AI-based fundus-camera networks and OCT-angiography units for microvascular mapping.
Glaucoma follows with innovation in micro-invasive implants that lower intra-ocular pressure while reducing recovery time. Cataract solutions continue to benefit from premium multifocal- and toric-lens demand among self-pay and medical-tourism cases. Vendors are introducing disposable vitrectomy packs and dual-platform phaco systems to optimise operating-room turnover in high-volume centres, sustaining overall sales momentum despite price pressures.
By End-User: Ambulatory Surgery Centers Capture Outpatient Shift
Hospitals captured 45.71% of total expenditure in 2024, leveraging integrated care pathways and capital-budget cycles. Yet Ambulatory Surgery Centers (ASCs) are slated for a 6.92% CAGR, mirroring a global pivot toward day-case ophthalmology, especially cataract and LASIK procedures. Government incentives that lift private-sector participation to 68% by 2030 encourage investors to build ASC networks equipped with femtosecond lasers, phaco platforms, and point-of-care diagnostics—all sourced from the Saudi Arabia ophthalmic devices market.
Specialty ophthalmic clinics also scale quickly as regional chains expand footprints beyond Tier-1 cities. These clinics concentrate on refractive and retina-care niches, purchasing compact imaging towers and portable lasers to fit smaller surgical suites. Hospitals still dominate complex ocular-oncology, paediatric, and trauma cases, ensuring baseline demand for high-acuity microscopes and vitrectomy consoles.
Competitive Landscape
The Saudi Arabia ophthalmic devices market features a moderate concentration. Global OEMs such as Alcon, Carl Zeiss Meditec, Johnson & Johnson Vision, and Bausch + Lomb dominate high-tech segments, leveraging broad portfolios and service networks. Alcon’s Experience Center in Jeddah provides surgeon training and on-site demonstrations, consolidating its influence over premium-device procurement. Multinationals hold a strong foothold in diagnostic imaging and surgical disposables, sectors requiring capital intensity and regulatory experience.
Local and regional chains, including Magrabi Health and Saudi German Hospital Group, compete on service breadth and geographic coverage, often partnering with global suppliers for technology transfers and joint-training initiatives. The rise of AI-based tele-retinopathy platforms creates space for software-driven entrants that differentiate through algorithm accuracy rather than hardware pedigree. Import duties and SFDA timelines, however, favor established distributors that can navigate compliance and finance inventory.
White-space opportunities exist in mobile screening units, low-cost portable fundus cameras, and technician training services. International start-ups offering handheld OCT and smartphone-based anterior-segment imaging may gain traction if they secure authorized-representative partnerships and local technical support. Price-sensitive public tenders still consider value over premium features, positioning mid-tier vendors for share gains once SABER procedures stabilize.
Saudi Arabia Ophthalmic Devices Industry Leaders
-
Alcon Inc
-
Bausch Health Companies Inc
-
Carl Zeiss Meditec AG
-
Johnson & Johnson Vision Care
-
EssilorLuxottica SA
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- April 2025: The World Council of Optometry chose Riyadh to host the 6th World Congress of Optometry in 2026, emphasizing education and research collaboration.
- March 2025: Alcon inaugurated its first Alcon Experience Center in Jeddah, signing training pacts with four leading hospitals to deepen surgical-skill development.
- February 2025: Almoosa Health reported FY 2024 revenue growth of 22.8% to SAR 1,202.3 million and announced plans to double bed capacity by 2028 in line with Vision 2030 goals.
- November 2024: The SFDA released MDS G002 version 3.0, refining pathways for innovative medical-device approvals, including ophthalmic equipment.
- January 2024: SASO adopted new product-safety regulations applicable to ophthalmic devices, strengthening quality-control enforcement.
Saudi Arabia Ophthalmic Devices Market Report Scope
As per the scope of the report, ophthalmology is a branch of medical science that deals with structure, function, and various diseases related to the eye. Ophthalmic devices are medical equipment designed for diagnosis, surgical, and vision correction purposes. The Saudi Arabia Ophthalmic Devices Market is segmented by Device (Surgical Devices, Diagnostic and Monitoring Devices, and Vision Correction Devices). The report offers the value (in USD million) for the above segments.
| Diagnostic & Monitoring Devices | OCT Scanners |
| Fundus & Retinal Cameras | |
| Autorefractors & Keratometers | |
| Corneal Topography Systems | |
| Ultrasound Imaging Systems | |
| Perimeters & Tonometers | |
| Other Diagnostic & Monitoring Devices | |
| Surgical Devices | Cataract Surgical Devices |
| Vitreoretinal Surgical Devices | |
| Refreactive Surgical Devices | |
| Glaucoma Surgical Devices | |
| Other Surgical Devices | |
| Vision Care Devices | Spectacles Frames & Lenses |
| Contact Lenses |
| Cataract |
| Glaucoma |
| Diabetic Retinopathy |
| Other Disease Indications |
| Hospitals |
| Specialty Ophthalmic Clinics |
| Ambulatory Surgery Centers (ASCs) |
| Other End-users |
| By Device Type | Diagnostic & Monitoring Devices | OCT Scanners |
| Fundus & Retinal Cameras | ||
| Autorefractors & Keratometers | ||
| Corneal Topography Systems | ||
| Ultrasound Imaging Systems | ||
| Perimeters & Tonometers | ||
| Other Diagnostic & Monitoring Devices | ||
| Surgical Devices | Cataract Surgical Devices | |
| Vitreoretinal Surgical Devices | ||
| Refreactive Surgical Devices | ||
| Glaucoma Surgical Devices | ||
| Other Surgical Devices | ||
| Vision Care Devices | Spectacles Frames & Lenses | |
| Contact Lenses | ||
| By Disease Indication | Cataract | |
| Glaucoma | ||
| Diabetic Retinopathy | ||
| Other Disease Indications | ||
| By End-user | Hospitals | |
| Specialty Ophthalmic Clinics | ||
| Ambulatory Surgery Centers (ASCs) | ||
| Other End-users | ||
Key Questions Answered in the Report
What is the current value of the Saudi Arabia ophthalmic devices market?
The market is valued at USD 0.58 billion in 2025 and is projected to rise to USD 0.77 billion by 2030.
Which device category is expanding the fastest?
Diagnostic & Monitoring Devices are forecast to grow at a 7.86% CAGR between 2025 and 2030, driven by AI-enabled imaging adoption.
How significant is diabetic retinopathy in driving demand?
Diabetic retinopathy affects 31% of diabetics, spurring rapid uptake of AI-based screening and making it the fastest-growing disease segment at a 7.04% CAGR.
Why are Ambulatory Surgery Centers gaining traction?
ASCs benefit from cost efficiencies and Vision 2030’s privatization push, resulting in an expected 6.9% CAGR through 2030 for ophthalmic procedures.
What regulations influence import pricing?
SFDA registration, ISO 13485 compliance, and the SABER platform add to import costs, increasing prices by around 15% for high-end devices.
Where are premium elective surgeries concentrated?
Riyadh and Jeddah host most premium LASIK and cataract procedures, supported by centers such as Magrabi Health and new facilities like Alcon’s Experience Center.
Page last updated on: